JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment.

<h2>OBJECTIVE:</h2>To assess the pharmacokinetics of isoniazid (INH) at 10 mg/kg/day among Indian children.<h2>METHODS:</h2>INH levels were estimated using liquid chromatography-tandem mass spectroscopy in 35 children aged 1&ndash;15 years on daily anti-tuberculosis treatment. Blood samples were collected 0, 1, 2, 3, 6 and 24 h after INH administration. The maximum concentration (Cmax ) and area under the curve (AUC0&ndash;24 ) were determined. The normal therapeutic range for Cmax is 3&ndash;5 &mu;g/ml. An AUC of &lt;10.52 &mu;g&bull;h/ml for INH is low.<h2>RESULTS:</h2>The mean Cmax was 8.3 &plusmn; 4.28 &mu;g/ml and was attained in 1.22 &plusmn; 0.5 h, with a median time to Cmax (Tmax ) of 1 h. The mean AUC for INH was 46.23 &plusmn; 34.82 &mu;g&bull;h/ml. Children aged 1&ndash;4.9 years, 5&ndash;10 years and &gt;10 years had a mean Cmax of respectively 9.87 &plusmn; 5.75 &mu;g/ml, 7.62 &plusmn; 3.37 &mu;g/ml and 7.21 &plusmn; 2.50 &mu;g/ml (<italic>P &equals;</italic> 0.08) and a mean AUC of respectively 60.97 &plusmn; 49.90 &mu;g&bull;h/ml, 38.95 &plusmn; 22.28 &mu;g&bull;h/ml and 36.09 &plusmn; 13.56 &mu;g&bull;h/ml (<italic>P &equals;</italic> 0.29). The mean Cmax in children taking fixed-drug combinations and individual drugs was respectively 9.07 &plusmn; 4.67 &mu;g/ml and 7.43 &plusmn; 3.71 &mu;g/ml (<italic>P &equals;</italic> 0.26); the mean AUC was respectively 50.48 &plusmn; 38.38 &mu;g&bull;h/ml and 41.20 &plusmn; 30.52 &mu;g&bull;h/ml (<italic>P &equals;</italic> 0.44). Two children had hepatitis.<h2>CONCLUSION:</h2>Most Indian children had higher than normal INH AUC and Cmax values<italic>.</italic> It is necessary to determine the ideal dose of INH in Indian children using the genotypic acetylator status of the patients and pharmacokinetic toxicity analysis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app